Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure

E-ISSN： 1545-5017|49|7|1025-1029

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.49, Iss.7, 2007-12, pp. : 1025-1029

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 1538-7933, Iss. 10, 2015-10 ,pp. : 1787-1789

John Wiley & Sons Inc

Access to resources Recommend Favorite

Topical bovine thrombin and adverse events: a review of the literature

By Clark John Crean Sheila Reynolds Matthew W.

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2071-2087

Informa Healthcare

Access to resources Recommend Favorite

Successful use of recombinant factor VIIa for management of severe menorrhagia in an adolescent with an acquired inhibitor of human thrombin

ACTA PAEDIATRICA, Vol. 93, Iss. 6, 2004-06 ,pp. : 841-843

John Wiley & Sons Inc

Access to resources Recommend Favorite

More on: pathogenic antibodies to coagulation factors. Part II: fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, protein C and von Willebrand factor

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 282-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acquired FVIII and FIX Inhibitors after Pregnancy: A Case Report

Acta Haematologica, Vol. 136, Iss. 4, 2016-10 ,pp. : 229-232

Karger

Access to resources Recommend Favorite